Keyphrases
Plasma Parameters
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Clinically Significant Prostate Cancer
100%
N1 Disease
58%
Radical Prostatectomy
16%
Area under the ROC Curve
16%
AIMS™
8%
Regression Analysis
8%
Logistic Regression
8%
Working Diagnosis
8%
Prognostic Value
8%
Lymph Node Metastasis
8%
Prostate-specific Antigen
8%
Time-resolved Fluorescence Immunoassay (TRFIA)
8%
Area under the Receiver Operating Characteristic Curve
8%
Angiogenesis
8%
Tumorigenesis
8%
Receiver Operating Characteristic Curve
8%
Prognostic Information
8%
Adverse Prognostic Factor
8%
Receptor II
8%
Receiver Operating Characteristic
8%
Predictive Information
8%
Diagnostic Parameters
8%
Biopsy Gleason Score
8%
Clinical Tumor Stage
8%
Medicine and Dentistry
Prostate Cancer
100%
Urokinase Receptor
100%
Disease
66%
Biopsy
16%
Prostatectomy
16%
Diagnosis
8%
Logistic Regression Analysis
8%
Cancer Staging
8%
Prognostic Factor
8%
Lymph Node Metastasis
8%
Prostate Specific Antigen
8%
Carcinogenesis
8%
Angiogenesis
8%
Immunoassay
8%
Gleason Score
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Urokinase Receptor
100%
Disease
66%
Cancer Staging
8%
Immunoassay
8%
Prostate Specific Antigen
8%
Carcinogenesis
8%
Lymph Node Metastasis
8%
Gleason Score
8%
Immunology and Microbiology
Blood Level
100%
Urokinase Receptor
100%
Prostate
41%
Lymph Node
8%
Angiogenesis
8%
Cancer Staging
8%
Immunoassay
8%
Prostate Specific Antigen
8%
Gleason Score
8%
Biochemistry, Genetics and Molecular Biology
Blood Level
100%
Urokinase Receptor
100%
Immunoassay
8%
Angiogenesis
8%
Carcinogenesis
8%
Prostate-Specific Antigen
8%
Cancer Staging
8%
Gleason Score
8%